FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091941736> ?p ?o ?g. }

• W2091941736 endingPage "346" @default.
• W2091941736 startingPage "341" @default.
• W2091941736 abstract "The long-term results for patients with recurrent ovarian cancer (ROC) are poor. There is a need to optimize treatment strategies to improve outcome by avoiding ineffective regimens which are often associated with exacerbated side-effects. Individualized chemotherapy regimens guided by a chemosensitivity assay (ATP-tumor chemosensitivity assay) have already been used successfully to direct chemotherapy. Taking the results of this assay into account, application of drug combinations appears more advisable. Here we present a systematic evaluation of toxicities seen with individualized chemotherapy for ROC. A total of 62 patients who received 314 cycles of antineoplastic therapies were evaluated. Three single agents (topotecan, paclitaxel and gemcitabine) and five combinations (cisplatin/gemcitabine, carbopatin/gemcitabine, gemcitabine/treosulfan, mitoxantrone/paclitaxel and carboplatin/paclitaxel) were examined. With respect to myelotoxicity, most single agents except topotecan revealed favorable results in comparison to drug combinations. However, this observation lacks statistical significance. Generally, severe myelosuppression was rare. The highest incidence of leukopenia was seen in regimens with mitoxantrone/paclitaxel or gemcitabine/treosulfan, respectively. Thrombocytopenia accompanied most commonly a topotecan therapy. In the present study combination regimens tend to be more toxic than monotherapies. When response rates are comparable, empirically chosen treatment combination therapies should only be practiced in carefully planned clinical studies." @default.
• W2091941736 created "2016-06-24" @default.
• W2091941736 creator A5005726838 @default.
• W2091941736 creator A5011867605 @default.
• W2091941736 creator A5015562881 @default.
• W2091941736 creator A5037195979 @default.
• W2091941736 creator A5071830607 @default.
• W2091941736 creator A5072370480 @default.
• W2091941736 creator A5088507107 @default.
• W2091941736 date "2003-06-01" @default.
• W2091941736 modified "2023-09-26" @default.
• W2091941736 title "Hematological side-effect profiles of individualized chemotherapy regimen for recurrent ovarian cancer" @default.
• W2091941736 cites W1831044128 @default.
• W2091941736 cites W1880772556 @default.
• W2091941736 cites W1905580151 @default.
• W2091941736 cites W1913802169 @default.
• W2091941736 cites W1939163116 @default.
• W2091941736 cites W2000963380 @default.
• W2091941736 cites W2017729051 @default.
• W2091941736 cites W2045826321 @default.
• W2091941736 cites W2051000943 @default.
• W2091941736 cites W2057776946 @default.
• W2091941736 cites W2073403282 @default.
• W2091941736 cites W2081033831 @default.
• W2091941736 cites W2088605481 @default.
• W2091941736 cites W2098840563 @default.
• W2091941736 cites W2102554779 @default.
• W2091941736 cites W2133894270 @default.
• W2091941736 cites W2154737435 @default.
• W2091941736 doi "https://doi.org/10.1097/00001813-200306000-00003" @default.
• W2091941736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12782939" @default.
• W2091941736 hasPublicationYear "2003" @default.
• W2091941736 type Work @default.
• W2091941736 sameAs 2091941736 @default.
• W2091941736 citedByCount "22" @default.
• W2091941736 countsByYear W20919417362012 @default.
• W2091941736 countsByYear W20919417362013 @default.
• W2091941736 countsByYear W20919417362014 @default.
• W2091941736 countsByYear W20919417362015 @default.
• W2091941736 countsByYear W20919417362016 @default.
• W2091941736 countsByYear W20919417362018 @default.
• W2091941736 countsByYear W20919417362019 @default.
• W2091941736 countsByYear W20919417362020 @default.
• W2091941736 crossrefType "journal-article" @default.
• W2091941736 hasAuthorship W2091941736A5005726838 @default.
• W2091941736 hasAuthorship W2091941736A5011867605 @default.
• W2091941736 hasAuthorship W2091941736A5015562881 @default.
• W2091941736 hasAuthorship W2091941736A5037195979 @default.
• W2091941736 hasAuthorship W2091941736A5071830607 @default.
• W2091941736 hasAuthorship W2091941736A5072370480 @default.
• W2091941736 hasAuthorship W2091941736A5088507107 @default.
• W2091941736 hasConcept C121608353 @default.
• W2091941736 hasConcept C126322002 @default.
• W2091941736 hasConcept C143998085 @default.
• W2091941736 hasConcept C2776694085 @default.
• W2091941736 hasConcept C2776755627 @default.
• W2091941736 hasConcept C2777292972 @default.
• W2091941736 hasConcept C2778119113 @default.
• W2091941736 hasConcept C2778239845 @default.
• W2091941736 hasConcept C2779178397 @default.
• W2091941736 hasConcept C2779263901 @default.
• W2091941736 hasConcept C2780258809 @default.
• W2091941736 hasConcept C2780427987 @default.
• W2091941736 hasConcept C2780873365 @default.
• W2091941736 hasConcept C2780923524 @default.
• W2091941736 hasConcept C2781209748 @default.
• W2091941736 hasConcept C2781413609 @default.
• W2091941736 hasConcept C2781451048 @default.
• W2091941736 hasConcept C3019864225 @default.
• W2091941736 hasConcept C71924100 @default.
• W2091941736 hasConcept C98274493 @default.
• W2091941736 hasConceptScore W2091941736C121608353 @default.
• W2091941736 hasConceptScore W2091941736C126322002 @default.
• W2091941736 hasConceptScore W2091941736C143998085 @default.
• W2091941736 hasConceptScore W2091941736C2776694085 @default.
• W2091941736 hasConceptScore W2091941736C2776755627 @default.
• W2091941736 hasConceptScore W2091941736C2777292972 @default.
• W2091941736 hasConceptScore W2091941736C2778119113 @default.
• W2091941736 hasConceptScore W2091941736C2778239845 @default.
• W2091941736 hasConceptScore W2091941736C2779178397 @default.
• W2091941736 hasConceptScore W2091941736C2779263901 @default.
• W2091941736 hasConceptScore W2091941736C2780258809 @default.
• W2091941736 hasConceptScore W2091941736C2780427987 @default.
• W2091941736 hasConceptScore W2091941736C2780873365 @default.
• W2091941736 hasConceptScore W2091941736C2780923524 @default.
• W2091941736 hasConceptScore W2091941736C2781209748 @default.
• W2091941736 hasConceptScore W2091941736C2781413609 @default.
• W2091941736 hasConceptScore W2091941736C2781451048 @default.
• W2091941736 hasConceptScore W2091941736C3019864225 @default.
• W2091941736 hasConceptScore W2091941736C71924100 @default.
• W2091941736 hasConceptScore W2091941736C98274493 @default.
• W2091941736 hasIssue "5" @default.
• W2091941736 hasLocation W20919417361 @default.
• W2091941736 hasLocation W20919417362 @default.
• W2091941736 hasOpenAccess W2091941736 @default.
• W2091941736 hasPrimaryLocation W20919417361 @default.
• W2091941736 hasRelatedWork W187925780 @default.
• W2091941736 hasRelatedWork W1993880164 @default.

• next